Back to the drug test guide

MDMA (Ecstasy) Test Evidence

Has Caused a False Positive

3,4-Methylenedioxy-alpha-pyrrolidinohexanophenone

Source Pasi et al., J Appl Lab Med 2026

What It Found

  • In a study of this synthetic cathinone, investigators found evidence that metabolites may trigger the ecstasy screen.
  • Adding the unchanged drug did not itself produce a positive.

Keep in Mind

  • This is a nonprescription psychoactive-substance exposure.
  • The specific reactive metabolite was not established.

Test Studied

  • Syva EMIT II Plus Ecstasy

Fenofibrate

Source Bugier et al., Mil Med 2016

What It Found

  • In a French military cohort, 22 of 15,169 urine screens were positive for MDMA.
  • GC-MS confirmed none.
  • The investigators identified fenofibric acid, a fenofibrate metabolite, in the investigation.

Keep in Mind

  • The cohort was not limited to people taking fenofibrate and cannot estimate their individual risk.

Source Quesada et al., J Anal Toxicol 2015

Keep in Mind

  • In a separate case, the measured free metabolite alone did not fully explain the signal.

Labetalol

Source Ayala-Lopez et al., J Anal Toxicol 2022

What It Found

  • A clinical-record signal prompted laboratory testing.
  • Urine spiked with labetalol at 200 micrograms/mL produced a positive MDMA result on this cup.

Keep in Mind

  • The experiment used added parent drug.
  • This concentration is not a patient dose or a clinical risk estimate.

Test Studied

  • Alere Integrated E-Z Split Key Cup II, MDMA channel

Mebeverine

Source Moncef et al., Acta Clin Belg 2026

What It Found

  • Three treated patients screened positive while GC-MS detected neither MDMA nor MDA.
  • Controlled administration reproduced positive screens.
  • Mebeverine O-desmethyl-butanol was consistently present.

Keep in Mind

  • Parent mebeverine spiked at the tested concentration was negative.
  • The evidence implicates a metabolite.

Test Studied

  • 12-panel lateral-flow urine test, MDMA cutoff 500 ng/mL

Also cited: Bedussi et al., Br J Clin Pharmacol 2021

Metoprolol

Source Leclercq et al., J Anal Toxicol 2020

What It Found

  • After metoprolol poisoning, the reported MDMA results did not confirm by GC-MS.
  • Metoprolol added to urine also triggered the MDMA screen.

Keep in Mind

  • The two tested metabolites only reacted with the amphetamine screen.
  • The MDMA evidence concerns parent metoprolol and poisoning.

Test Studied

  • Abbott MULTIGENT Ecstasy

Stiripentol

Source Magny et al., Ann Biol Clin (Paris) 2025

What It Found

  • In a child receiving stiripentol, two MDMA-positive screens failed GC-MS confirmation.
  • Laboratory testing reproduced the reaction with stiripentol.
  • The third sample, at a lower drug concentration, screened negative.

Keep in Mind

  • This report concerns the kit and three samples from the same child.

Test Studied

  • Automated urine ecstasy immunoassay

Bupropion

Source Marin et al., J Anal Toxicol 2016

What It Found

  • A bupropion metabolite, erythrohydrobupropion, triggered a positive MDMA result at 10.5 micrograms/mL in synthetic urine.

Keep in Mind

  • This experiment does not establish how often MDMA screens turn positive during treatment.

Test Studied

  • Syva EMIT II Plus Ecstasy, 500 ng/mL cutoff

Fenofibric acid

Both sources Bugier et al., Mil Med 2016 Quesada et al., J Anal Toxicol 2015

What It Found

  • Testing identified fenofibric acid as a cross-reactant in a study prompted by patients taking fenofibrate.
  • Fenofibric acid is also an active medicinal ingredient.

Keep in Mind

  • The clinical cases cited involved fenofibrate treatment.
  • Direct case evidence for each fenofibric acid formulation was not established.

Test Studied

  • DRI Ecstasy

Depends on the Brand of Test

Meta-chlorophenylpiperazine

Both sources Regester et al., J Anal Toxicol 2015 Logan et al., J Anal Toxicol 2010

What It Found

  • The two ecstasy assays disagreed.

Keep in Mind

  • Whether m-CPP turns an ecstasy screen positive depends on which assay the lab used.

Source Regester et al., J Anal Toxicol 2015

What It Found

  • On the Microgenics DRI Ecstasy assay, m-CPP added to drug-free urine stayed negative at 100 µg/mL.

Keep in Mind

  • The laboratory concentrations do not predict a result in a patient.

Test Studied

  • Microgenics DRI Ecstasy on a Roche/Hitachi Modular P

Source Logan et al., J Anal Toxicol 2010

What It Found

  • On the EMIT II Ecstasy assay, an m-CPP standard cross-reacted, and urine from patients taking trazodone that screened positive contained trazodone and m-CPP with no MDMA by LC-MS/MS.

Test Studied

  • Siemens/Syva EMIT II Ecstasy

A Related Drug the Test Picks Up

4-CAP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-CAP challenge, Microgenics DRI Ecstasy gave a positive result at 20 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-Fluoroamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Fluoroamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 37.5 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-Fluoromethamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Fluoromethamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 11 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-Methylamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Methylamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-Methylthioamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Methylthioamphetamine challenge, Microgenics DRI Ecstasy gave a positive result at 2 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-APB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-APB challenge, Microgenics DRI Ecstasy gave a positive result at 2 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-APDB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-APDB challenge, Microgenics DRI Ecstasy gave a positive result at 0.2 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-APDI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-APDI challenge, Microgenics DRI Ecstasy gave a positive result at 20 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

6-APB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 6-APB challenge, Microgenics DRI Ecstasy gave a positive result at 16 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

BDB

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 33% cross-reactivity for BDB on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 15

Butylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Butylone challenge, Microgenics DRI Ecstasy gave a positive result at 60 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Ethylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Ethylone challenge, Microgenics DRI Ecstasy gave a positive result at 96 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Eutylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Eutylone challenge, Microgenics DRI Ecstasy gave a positive result at 55 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

MBDB

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 25% cross-reactivity for MBDB on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 13

MDA

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 56% cross-reactivity for MDA on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 14

MDEA

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 83% cross-reactivity for MDEA on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 16

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDEA challenge, Microgenics DRI Ecstasy gave a positive result at 0.4 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Both sources Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Regester et al., J Anal Toxicol 2015

Keep in Mind

  • The result depends on the reagent, the cutoff and the concentration in the specimen.

MDPPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDPPP challenge, Microgenics DRI Ecstasy gave a positive result at 95 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Methedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methedrone challenge, Microgenics DRI Ecstasy gave a positive result at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Methylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methylone challenge, Microgenics DRI Ecstasy gave a positive result at 80 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

PMA

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 11% cross-reactivity for PMA on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 18

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the PMA challenge, Microgenics DRI Ecstasy gave a positive result at 5 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Both sources Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Regester et al., J Anal Toxicol 2015

Keep in Mind

  • The result depends on the reagent, the cutoff and the concentration in the specimen.

PMMA

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 29% cross-reactivity for PMMA on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 17

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the PMMA challenge, Microgenics DRI Ecstasy gave a positive result at 2 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Both sources Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009 Regester et al., J Anal Toxicol 2015

Keep in Mind

  • The result depends on the reagent, the cutoff and the concentration in the specimen.

The Test Is Made to Find It

MDMA

Source Krasowski et al. Additional file 1. Historical assay cross-reactivity tables and reagent…, 2009

What It Found

  • The 2009 comparison lists 100% cross-reactivity for MDMA on the Microgenics DRI screen.

Keep in Mind

  • This laboratory comparison used historical reagents.
  • It gives no frequency after routine use.
  • The result depends on the reagent, the cutoff and the concentration in the specimen.

Tests Studied

  • Microgenics DRI MDMA (ecstasy) screen, Krasowski et al. supplement, J
  • MDMA, row 12

Tested: No False Positive Found

2,5-Dimethoxyamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2,5-Dimethoxyamphetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2,5-Dimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

2-Aminoindane

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2-Aminoindane challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2-DPMP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2-DPMP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

25B-NBOMe

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 25B-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

25C-NBOMe

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 25C-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

25I-NBOMe

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 25I-NBOMe challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2C-B

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-B challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2C-C

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-C challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2C-E

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-E challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2C-I

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-I challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2C-N

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-N did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

2C-T

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-T did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

2C-T-13

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-T-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

2C-T-17

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-T-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

2C-T-2

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T-2 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-T-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

2C-T-4

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T-4 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

2C-T-5

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-T-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

2C-T-7

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 2C-T-7 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 2C-T-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

3,4,5-Trimethoxyamphetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 3,4,5-Trimethoxyamphetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • 3,4,5-Trimethoxyamphetamine did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

3,4-Dimethylmethcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 3,4-Dimethylmethcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

3-Trifluoromethylphenylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 3-TFMPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-EEC

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-EEC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-HO-DET

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-HO-DET challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-MEC

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-MEC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-MePPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-MePPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-Methoxyphencyclidine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-Methoxyphencyclidine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-MPBP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-MPBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

4-TFMPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 4-TFMPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-IAI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-IAI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-IT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-IT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-MeO-AMT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-AMT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-MeO-DALT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-DALT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-MeO-DiPT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-DiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-MeO-DMT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-DMT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

5-MeO-MiPT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the 5-MeO-MiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Acetaminophen

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The study found no cup interference from Acetaminophen at 1,000 ng/mL in drug-free urine.

Keep in Mind

  • The finding is limited to the device configuration and concentration tested.

Test Studied

  • NexScreen urine MDMA strip

ALEPH

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • ALEPH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

ALEPH-13

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • ALEPH-13 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

ALEPH-17

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • ALEPH-17 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

ALEPH-2

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • ALEPH-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

ALEPH-5

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • ALEPH-5 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

ALEPH-7

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • ALEPH-7 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Alpha-methyltryptamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-methyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Alpha-PBP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Alpha-PPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Alpha-PVP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PVP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Alpha-PVT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Alpha-PVT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Benocyclidine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Benocyclidine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Benzedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Benzedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Benzylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Benzylpiperazine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

BOB

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • BOB did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

BOD

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • BOD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

BOH

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • BOH did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

BOHD

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • BOHD did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Bromo-DragonFLY

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Bromo-DragonFLY challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Buphedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Buphedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Cathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Cathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

D2PM

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the D2PM challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Dextromethorphan

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The study found no cup interference from Dextromethorphan at 1,000 ng/mL in drug-free urine.

Keep in Mind

  • The finding is limited to the device configuration and concentration tested.

Test Studied

  • NexScreen urine MDMA strip

Dibenzylpiperazine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dibenzylpiperazine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Diethylpropion

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Diethylpropion challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Dimethylamylamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dimethylamylamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Dimethylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dimethylone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Dimethyltryptamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dimethyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Diphenhydramine

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The study found no cup interference from Diphenhydramine at 1,000 ng/mL in drug-free urine.

Keep in Mind

  • The finding is limited to the device configuration and concentration tested.

Test Studied

  • NexScreen urine MDMA strip

Dipropyltryptamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Dipropyltryptamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

DiPT

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DiPT challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

DOB

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOB challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

DOC

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOC challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • DOC did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

DOET

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOET challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • DOET did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

DOI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • DOI did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Both sources Regester et al., J Anal Toxicol 2015 Nieddu et al., J Anal Toxicol 2016

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.
  • Different antibody formulations can give different results.

DOM

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the DOM challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

DON

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • DON did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

DOPR

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • DOPR did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

Escaline

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Escaline challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Ethcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Ethcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Flephedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Flephedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

MDAI

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDAI challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

MDBZ

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • MDBZ did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

MDCPM

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • MDCPM did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

MDIP

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • MDIP did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

MDPBP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MDPBP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Mephedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Mephedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Meprobamate

Source Lin et al., J Anal Toxicol 2013

What It Found

  • The study found no cup interference from Meprobamate at 1,000 ng/mL in drug-free urine.

Keep in Mind

  • The finding is limited to the device configuration and concentration tested.

Test Studied

  • NexScreen urine MDMA strip

Mescaline

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Mescaline challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Methcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Methiopropamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methiopropamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Methoxetamine

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methoxetamine challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Methylenedioxypyrovalerone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Methylenedioxypyrovalerone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

MOPPP

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MOPPP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

MPHP (study designation)

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MPHP challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

MT-45

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the MT-45 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

N,N-Dimethylcathinone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the N,N-Dimethylcathinone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Naphyrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Naphyrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Pentedrone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Pentedrone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Pentylone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Pentylone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

Pyrovalerone

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the Pyrovalerone challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy

TMA-2

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • TMA-2 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

TMA-3

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • TMA-3 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

TMA-6

Source Nieddu et al., J Anal Toxicol 2016

What It Found

  • TMA-6 did not give a positive Neogen Methamphetamine/MDMA urine screen at tested concentrations up to 10,000 ng/mL.

Keep in Mind

  • Urine results were evaluated separately from blood and oral fluid.
  • Different antibody formulations can give different results.

Test Studied

  • Neogen Methamphetamine/MDMA urine ELISA

WIN 35,428

Source Regester et al., J Anal Toxicol 2015

What It Found

  • In the WIN 35,428 challenge, Microgenics DRI Ecstasy stayed negative at 100 µg/mL.

Keep in Mind

  • These were pure reference compounds added to drug-free human urine.
  • The concentrations do not predict a positive result after use in a patient.

Test Studied

  • Urine screening on Roche/Hitachi Modular P, Microgenics DRI Ecstasy